Hi @Leo65
as a non-biomedical scientist, I was very interested to read about your belief in the science.
At this pivotal moment for MSB, with such a focus on analytical process, there's such a dearth of comment from holders on HC:MSB about, for example, relative potency, or comparability studies, or the FDA's position on recognition of ICH Q2 (R2) that it would be good to read some new and informed points of view.
Personally, I'm particularly interested in whether, from public statements etc, you'd consider MSB might reasonably be thought at this time to have a well-characterised in-house material or whether we are going to have to rely on FDA finally getting round to endorsing a national/ international reference standard.
I'm guessing from your investment what your answer might be. And, yes, we have matched investments.
Cheers
GLTAH
- Forums
- ASX - By Stock
- MSB
- Taken up the entitlement?
Taken up the entitlement?, page-255
-
- There are more pages in this discussion • 290 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B |
Open | High | Low | Value | Volume |
$1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8683 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 32999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8683 | 1.155 |
7 | 295447 | 1.150 |
3 | 70786 | 1.145 |
6 | 196386 | 1.140 |
3 | 75486 | 1.135 |
Price($) | Vol. | No. |
---|---|---|
1.165 | 32999 | 1 |
1.170 | 62618 | 6 |
1.175 | 48590 | 3 |
1.180 | 79079 | 4 |
1.185 | 17090 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online